*
*Glomerulonephritis|36171008
*
*,
also
known|36692007
as
*
*glomerular nephritis|68288006
*
*,
abbreviated
*
*GN|223558001
*
*,
is
a renal disease|90708001
(usually
of
both
kidneys|64033007|17373004
)
characterized
by inflammation|257552002
of the glomeruli,|68288006
or
small blood vessels|27915009
in the kidneys.|64033007|17373004

It
may
present|52101004|246105001
with isolated hematuria|46651001|53298000
and/or
proteinuria|29738008
(blood|87612001|119273009
or
protein|88878007
in the urine|78014005
;
or
as a nephrotic syndrome,|52254009
a nephritic syndrome,|7724006
acute renal failure,|14669001
or
chronic renal failure.|46177005

They
are
categorized
into several different pathological patterns,|261028005|263735002|394595002|272135003|261028005|263735002|29458008|272135003
which
are
broadly
grouped|255504006
into non-proliferative|30217000
or
proliferative types.|30217000|261664005

Diagnosing|439401001
the pattern|272135003
of GN|223558001
is
important
because
the outcome|394617004
and
treatment|276239002|416118004
differs
in different types.|263735002|261664005

Primary causes|63161005|134198009|261424001|134198009
are
intrinsic|260521003|255406006
to the kidney.|64033007|17373004|181414000

Secondary causes|2603003|134198009|81170007|134198009
are
associated|47429007
with certain infections|17162000
(bacterial, viral|409822003
or
parasitic pathogens|264418008
)
,
drugs,|410942007
systemic disorders|370117001
(SLE,|55464009
vasculitis|31996006
)
,
or
diabetes.|73211009

Thin basement membrane disease|236418003
is
an autosomal dominant inherited disease|263681008|32895009
characterized
by thin glomerular basement membranes|18043004|68288006|68989006|18043004|197679002|68989006
on electron microscopy.|73512001

It
is
a benign condition|30807003|260905004
that
causes|134198009
persistent microscopic hematuria.|281857003

This also
may
cause|23981006|134198009
proteinuria|29738008
which
is
usually mild|255604002
and
overall prognosis|20481000
is
excellent.|425405005

This
is
characterised
by absence|2667000|418560003
of increase|260366006
in the number|410680006|410681005
of cells|4421005
(lack|41277001
of hypercellularity|76197007
)
in the glomeruli.|68288006

They usually
cause|23981006|134198009
nephrotic syndrome.|52254009

This
includes|55919000
the following types|255260001|261664005
:

This form|246176004
of GN|223558001
causes|134198009
78.4%
of nephrotic syndrome|52254009
in children,|410601007|160499008
but
only 20%|50607009|420295001
in adults.|133936004

As the name
indicates|410535002
,
there
are
no changes|243326001|263703002
visible|24054004
on simple light microscopy,|13673007|104157003
but
on electron microscopy there|73512001
is
fusion|31883006|122501008
of podocytes
(supportive cells|4421005
in the glomerulus|68288006
).

Immunohistochemistry staining|117617002|127790008
is
negative.|260385009

Treatment|276239002|416118004
consists
of supportive care|243114000
for the massive fluid accumulation|46998006|17672001
in the patients body|116154003|279495008|116154003|123037004
(
= oedema|423666004
)
and
as well as
steroids to|116566001
halt
the disease process|64572001|415178003
(typically prednisone 1 mg/kg|116602009
).

Over 90%|264705001|264703008
of children|410601007|160499008
respond
well|20572008
to steroids,|116566001
being
essentially
cured
after 3 months|260313008|258706009
of treatment.|276239002|416118004

Adults|133936004
have
a lower response rate|261122009
(80%
).

Failure to|76797004
respond
to steroids|116566001
('steroid resistant'|116566001|30714006
)
or
return|7528007
of the disease|64572001
when
steroids|116566001
are
stopped|385654001
('steroid|116566001
dependent'|371154000
)
may
require
cytotoxic therapy
(
such as cyclosporin,|387467008
which
is
associated|47429007
with many side-effects.

FSGS|236403004
may
be
primary|63161005|261424001
or
secondary|2603003|81170007
to reflux nephropathy,|197764002
Alport syndrome,|399340005
heroin abuse|387341002|26416006|387341002|386702006|387341002|417928002
or
HIV.|19030005|86406008|402916007

FSGS|236403004
presents|52101004|246105001
as a nephrotic syndrome|52254009
with varying degrees|246173007
of impaired renal function|236423003
(
seen
as a rising serum creatinine,|113075003|365757006
hypertension|38341003
).

As the name
suggests
,
only certain foci|50607009|17162000|87017008|50607009|255544004|87017008|420295001|17162000|87017008|420295001|255544004|87017008
of glomeruli|68288006
within the kidney|64033007|17373004|181414000
are
affected|247591002|248448006
,
and
then only
a segment|264193005
of an individual glomerulus.|125676002|68288006|385435006|68288006

The pathological lesion|394595002|29458008
is
sclerosis|43846000
(fibrosis|263756000
)
within the glomerulus|68288006
and
hyalinisation|19010006
of the feeding arterioles,|129007004|28225005
but
no increase|260366006
in the number|410680006|410681005
of cells|4421005
(hence non-proliferative|30217000
).

The hyaline
is
an amorphous material,|260769002
pink,|371243003
homogeneous,
resulting|42752001
from combination|89780004
of plasma proteins,|395835001
increased|35105006|260366006
mesangial matrix|33238007
and
collagen.|61472002

Staining|127790008
for antibodies|68498002
and
complement|20823009
is
essentially negative.|260385009

Steroids|116566001
are
often|70232002
tried
but
not
shown
effective.|255403003|254648000

50%
of people|125676002
with FSGS|236403004
continue|255238004
to
have
progressive deterioration|255314001
of kidney function,|11953005
ending|261782000|422117008
in renal failure.|42399005

Membranous glomerulonephritis (MGN),|77182004
a relatively common type|72906007|261664005
of glomerulonephritis|36171008
in adults,|133936004
frequently|70232002
produces
a mixed nephrotic|26242008
and
nephritic picture.|257444003|257445002

Its cause|134198009
is
usually
unknown|261665006
,
but
may
be
associated|47429007
with cancers|363346000
of the lung|39607008|181216001
and
bowel,|261093006
infection
such as hepatitis|128241005|40468003|396423004
and
malaria,|248437004
drugs|410942007
including|55919000
penicillamine,|387235007
and
connective tissue diseases|105969002
such as systemic lupus erythematosus.|55464009

Individuals|125676002|385435006
with cerebral shunts|442119001|257351008|125319009
are
at risk|410519009
of developing shunt nephritis,|37085009
which frequently|70232002
produces
MGN.|77182004

Microscopically,
MGN|77182004
is
characterized
by a thickened glomerular basement membrane|263899003|68288006|68989006|263899003|197679002|68989006
without a hypercellular glomerulus.|76197007|68288006

Immunofluorescence|5733007|30662005
demonstrates
diffuse granular uptake|19648000|15933001|258763004
of IgG.

The basement membrane|68989006
may
completely
surround|355648006
the granular deposits,|15933001|46595003
forming|35810008
a "spike
and
dome" pattern.|261769008|272135003

Tubules also|95568003|13336003
display
the symptoms
of a typical Type III hypersensitivity reaction,|83699005|421961002|83699005|421369008
which
causes|134198009
the endothelial cells to|45709008
proliferate
,
which
can
be
seen
under a light microscope|56242006|65473004|371268001|65473004
with a PAS stain.[2][3]|15947002

Prognosis|20481000
follows|367409002
the rule|10828004
of thirds|70905002
:
one-third|421379005|70905002
remain
with MGN indefinitely,|77182004
one-third remit,|421379005|70905002|255319006
and
one-third|421379005|70905002
progress|385651009
to end-stage renal failure.|46177005|433146000

As the glomerulonephritis progresses,|36171008|385651009
the tubules|95568003|13336003
of the kidney|64033007|17373004|181414000
become
infected,
leading|236874000
to atrophy|13331008
and
hyalinisation.|19010006

The kidney|64033007|17373004|181414000
appears
to
shrink.

Treatment|276239002|416118004
with corticosteroids|79440004
is
attempted
if
the disease progresses.|64572001|385651009

In extremely rare cases,|84638005|398241000|84638005|413769002|103356009|398241000|103356009|413769002
the disease|64572001
has
been
known|36692007
to run in families,|418060005|35359004|282476009|35359004
usually
passed
down
through the females.|248152002

This condition,|260905004
similarly,
is
called Familial Membranous Glomerulonephritis.|35359004|77182004|255401001|77182004

There
have
only
been
about nine documented cases|422113007|397934002|398241000|422113007|397934002|413769002
in the world.

This type|261664005
is
characterised
by increased number|35105006|410680006|35105006|410681005|260366006|410680006|260366006|410681005
of cells|4421005
in the glomerulus|68288006
(hypercellular|76197007
).

Usually
present|52101004|246105001
as a nephritic syndrome|7724006
and
usually
progress|385651009
to end-stage renal failure (ESRF)|46177005|433146000
over weeks|258705008
to years|258707000
(
depending
on type|261664005
).

[4]|260308009

IgA nephropathy|68779003
is
the most common type|4757001|72906007|261664005
of glomerulonephritis|36171008
in adults worldwide.|133936004

It usually
presents|52101004|246105001
as macroscopic haematuria|197941005
(visibly bloody urine|53298000
).

It occasionally
presents|52101004|246105001
as a nephrotic syndrome.|52254009

It often|70232002
affects|4065008
young males|84422007|248153007
within days|258703001
(24-48hrs
)
after an upper respiratory tract|58675001|361381009
or
gastrointestinal infection.|128398001

Microscopic examination|117259009
of biopsy specimens|258415003
shows
increased number|35105006|410680006|35105006|410681005|260366006|410680006|260366006|410681005
of mesangial cells|24259000
with increased matrix|35105006|260366006
(
the '
cement|80541002|59334006|419202002|34505008
'
that holds|421139008
everything together
).

Immuno-staining|127790008
is
positive|258758003|10828004
for immunoglobulin A deposits|446944008
within the matrix.

Prognosis|20481000
is
variable, 20% progress|255372005|385651009
to ESRF.

ACE inhibitors|372733002
are
the mainstay
of treatment.|276239002|416118004

This
is
a form|246176004
of GN|223558001
characterised
by IgA
deposits|46595003
in the mesangial regions|18602000|410673009
and
immunocytochemistry|395126005
is
required
for definitive diagnosis|261002007|439401001|261002007
of the disease.|64572001

The disease|64572001
can
be
primary|63161005|261424001
or
secondary|2603003|81170007
to liver|10200004|181268008
and
intestinal diseases.|85919009

It also
overlaps|24846002
with Henoch-Schonlein purpura,|191306005
a systemic renal disease|264578000|64033007|31099001|90708001
in children|410601007|160499008
in which similar IgA deposits|446944008
occur.|272120004

plasma polymeric IgA|419185008|412155002
is
increased|35105006|260366006
in IgA Nephropathy,|68779003
and
circulating IgA-|65929005
containing|42504009
immune complexes|23369004
can
be
found|404684003
in the blood|87612001|119273009
of some patients.|116154003

Plasma IgA|419185008
is
usually monomeric
and
polymeric plasma IgA|412155002|419185008
is
broken down|263690001
in the liver.|10200004|181268008

IgA
is
normally
found|404684003
in mucus.|49909006

There
are
two forms|420797005|246176004
of IgA
and
only IgA1|50607009|26898003|420295001|26898003
causes|134198009
nephrogenicity.

Characteristic finding|404684003
:

May
find
:

Post-infectious glomerulonephritis|236395002
can
occur|272120004
after essentially
any infection,
but
classically
occurs|272120004
after infection
with _Streptococcus pyogenes_.|80166006

It typically
occurs|272120004
10?14 days|258703001
after a skin|119325001|39937001|181469002
or
pharyngeal infection|54066008
with this bacterium.|409822003

Patients|116154003
present|52101004|246105001
with signs|72670004
and
symptoms
of glomerulonephritis.|36171008

Diagnosis|439401001
is
made
based|418836005
on these findings|404684003
in an individual|125676002|385435006
with a history|392521001
of recent streptococcal infection.|6493001|85769006

Streptococcal titers|58800005|118590008
in the blood|87612001|119273009
(antistreptolysin O titers|82703001
)
may
support|9096001|243114000
the diagnosis.|439401001

Light microscopy|104157003
demonstrates
diffuse endocapillary hypercellularity|19648000|76197007
due to proliferation|30217000
of endothelial|27168002
and
mesangial cells,|24259000
as well as
an influx
of neutrophils|116712007
and
monocytes.|55918008|67776007

The Bowman space|2687004|244284006
is
compressed,|37204000
in some cases|398241000|413769002
to the extent|255590007
that
this
produces
a crescent formation|264296008|11798007|264296008|255277001
characteristic
of crescentic glomerulonephritis.|236398000

Biopsy|86273004
is
seldom|103356009
done
as the disease usually|64572001
regresses
without complications.|116223007

Treatment|276239002|416118004
is
supportive,
and
the disease generally|64572001
resolves
in 2?4 weeks.|260306008|258705008

This
may
be
primary,|63161005|261424001
or
secondary|2603003|81170007
to SLE,|55464009
viral hepatitis,|3738000
or
hypocomplementemia.

One|421379005
sees|281004000
'hypercellular|76197007
and
hyperlobular' glomeruli|68288006
due to proliferation|30217000
of
both
cells|4421005
and
the matrix
within the mesangium.|18602000

Usually
presents|52101004|246105001
with a combined nephritic-nephrotic picture,|89780004|257444003|89780004|257445002
with inevitable progression to end stage renal failure.|246453008|46177005|246453008|433146000|246450006|46177005|246450006|433146000

The primary form|63161005|246176004|261424001|246176004
consists
of two types|420797005|261664005
:

In
both
types,|261664005
the basement membrane|68989006
may
develop
a 'tram-track' appearance,|38548008|257719005|386548000|38548008|257719005|255412001
due to duplication|89049001
and
splitting.|410714001

*
*Rapidly progressive glomerulonephritis|236392004
*
*
(Crescentic GN|2777009|223558001|264296008|223558001
)
has
a poor prognosis,|170969009
with rapid progression|255358001|246453008|255358001|246450006
to kidney failure|42399005
over weeks.|258705008

Steroid therapy|297279009
is
sometimes
used.|394850002

Any
of the above types|261183002|261664005
of GN|223558001
can
be
rapidly progressive.|418694008|255314001

Additionally
two|420797005
further causes|46053002|134198009
present|52101004|246105001
as solely RPGN.

Histopathology|394597005
:
The majority
of glomeruli|68288006
present|52101004|246105001
"crescents".|264296008

Formation|11798007|255277001
of crescents|264296008
is
initiated
by passage|255592004
of fibrin|113361004
into the Bowman space|2687004|244284006
as a result|394617004
of increased permeability|35105006|82540007|260366006|82540007
of glomerular basement membrane.|68288006|68989006|197679002|68989006

Fibrin|113361004
stimulates
the proliferation|30217000
of endothelial cells|45709008
of Bowman capsule,|91765006
and
an influx
of monocytes.|55918008|67776007

Rapid growing|255358001
and
fibrosis|263756000
of crescents|264296008
compresses|37204000
the capillary loops|20982000|261913007|255416003|261913007
and
decreases|260370003
the Bowman space,|2687004|244284006
which
leads|88488004|236874000
to renal failure|42399005
within weeks|258705008
or
months.|258706009

M
:
URI|54150009

anat/phys/devp/cell|4421005|362837007

noco/acba/cong/tumr,
sysi/epon,
urte

proc/itvp,
drug|410942007
(G4B,
blte,
urte

